Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for media industry professionals · Thursday, March 28, 2024 · 699,478,953 Articles · 3+ Million Readers

Global Glucose Biosensor Market 2016 Analysis and Forecast to 2022

Glucose Biosensor Market to Reach $30.5 billion with 10.29% CAGR Forecast to 2022

PUNE, INDIA, July 19, 2016 /EINPresswire.com/ -- According to research, the Global Glucose Biosensor Market is accounted for $15.3 billion in 2015 and is expected to reach $30.5 billion by 2022 growing at a CAGR of 10.29% from 2015 to 2022. Growing demand for expansion of technologically advanced products and non-invasive products are some of the primary factors favouring the market growth. Furthermore, increasing frequency of diabetes across the globe, need for early diabetes detection and patient awareness levels are some of the drivers fuelling the market growth. However, high cost, reluctance towards the adoption of the new treatment practices and slow rate of commercialization are the restraints limiting the market growth. The recent trends in Glucose Biosensors market are increasing adoption of the POC diagnostic kits and wearable healthcare devices.

Complete report details @ https://www.wiseguyreports.com/reports/456576-glucose-biosensor-global-market-outlook-2015-2022

Fluorescence segment is expected to capture the largest market share over the forecast period. North America is expected to witness highest growth rate in terms of value and share. High disease burden and the subsequent need to curb associated healthcare expenditure in the U.S. is attributing to the favorable North American market.
Some of the key players in the market include Roche Diagnostics, LifeScan Inc., Abbott Laboratories, Bayer, Medtronic Inc., Pinnacle Medical Solutions Inc., AgaMatrix Inc., Sanofi S.A., BioSense Medical Devices, LLC, Nova Biomedical, Lifesensors, Inc., Animas Corporation, Siemens Healthcare Diagnostics, Inc., F. Hoffman-La Roche and M-Biotech Limited.

Request a sample report @ https://www.wiseguyreports.com/sample-request/456576-glucose-biosensor-global-market-outlook-2015-2022

End User Covered:
• Hospitals
• Homecare Diagnostics
• Other end users
Type Covered:
• Amprometric Glucose Biosensors
• Fluorescence Glucose Biosensors
• Other types
What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Make an enquiry before buying this Report @ https://www.wiseguyreports.com/enquiry/456576-glucose-biosensor-global-market-outlook-2015-2022

Table of content
1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.7 End user Analysis
3.6 Emerging Markets

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Glucose Biosensor Market, By End User
5.1 Introduction
5.2 Hospitals
5.3 Homecare Diagnostics
5.4 Other end users

6 Global Glucose Biosensor Market, By Type
6.1 Introduction
6.2 Amprometric Glucose Biosensors
6.3 Fluorescence Glucose Biosensors
6.4 Other types

7 Global Glucose Biosensor Market, By Geography
7.1 North America
7.1.1 US
7.1.2 Canada
7.1.3 Mexico
7.2 Europe
7.2.1 Germany
7.2.2 France
7.2.3 Italy
7.2.4 UK
7.2.5 Spain
7.2.7 Rest of Europe
7.3 Asia Pacific
7.3.1 Japan
7.3.2 China
7.3.3 India
7.3.4 Australia
7.3.5 New Zealand
7.3.7 Rest of Asia Pacific
7.4 Rest of the World
7.4.1 Middle East
7.4.2 Brazil
7.4.3 Argentina
7.4.4 South Africa
7.4.5 Egypt

8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies

9 Company Profiling
9.1 Roche Diagnostics
9.2 LifeScan Inc.
9.3 Abbott Laboratories
9.4 Bayer
9.5 Medtronic Inc.
9.6 Pinnacle Medical Solutions Inc.
9.7 AgaMatrix Inc.
9.9 Sanofi S.A.
9.9 BioSense Medical Devices, LLC
9.10 Nova Biomedical
9.11 Lifesensors, Inc.
9.12 Animas Corporation
9.13 Siemens Healthcare Diagnostics, Inc.
9.14 F. Hoffman-La Roche
9.15 M-Biotech Limited

Buy this report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=456576

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Powered by EIN Presswire


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release